Short-term outcomes of non-ST segment elevation acute coronary syndrome after percutaneous coronary intervention: a

Ha Viet Trinh1,2, Dung Viet Nguyen2, Loi Doan Do1,3

  • 1Vietnam National Heart Institute, Bach Mai Hospital, Hanoi, Vietnam.

PubMed

Insights

Prognostic value of myocardial strain in non-ST-segment elevation acute coronary syndrome (NSTE-ACS) patients in Vietnam was assessed. Global longitudinal strain (GLS) after percutaneous coronary intervention (PCI) independently predicted major adverse cardiovascular events (MACE), identifying high-risk patients.

Area of Science:

  • Cardiology
  • Echocardiography
  • Acute Coronary Syndromes

Background:

  • Limited data exists on myocardial strain's prognostic value in non-ST-segment elevation acute coronary syndrome (NSTE-ACS) patients from low- and middle-income countries.
  • This study investigated the prognostic significance of left ventricular myocardial strain in Vietnamese NSTE-ACS patients post-percutaneous coronary intervention (PCI).

Purpose of the Study:

  • To evaluate the prognostic significance of left ventricular myocardial strain in NSTE-ACS patients after successful PCI.
  • To identify echocardiographic parameters that predict major adverse cardiovascular events (MACE) in this population.

Main Methods:

  • Prospective cohort study of 127 NSTE-ACS patients treated with PCI.
  • Speckle-tracking echocardiography assessed global longitudinal strain (GLS), global circumferential strain (GCS), and global radial strain (GRS) within 24 hours post-PCI.
  • 12-month follow-up analyzed the association between strain parameters and MACE using survival analysis and ROC curves.

Main Results:

  • 20.5% of patients experienced MACE within 12 months.
  • Impaired GLS, GCS, and GRS were significantly associated with MACE (p < 0.0001).
  • Higher (less negative) GLS was an independent predictor of MACE (HR: 1.62; p < 0.001) with excellent prognostic performance (AUC: 0.967).

Conclusions:

  • Post-PCI GLS, GCS, and GRS are impaired in NSTE-ACS patients who experience MACE, indicating cardiac dysfunction.
  • GLS is a valuable independent predictor of MACE after PCI in NSTE-ACS patients.
  • GLS can help identify high-risk patients for closer monitoring and tailored management.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
753
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
200
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
205
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
257
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
333
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
207